| text 
Program® Injectable Suspension (Lufenuron)
Product information on this website is for Non-U.S. residents only and is provided by Novartis Animal Health Inc. for general purposes only. Many veterinary products listed are available upon prescription only, and not all such products may be available in all countries. The product information is not intended to provide complete medical information. SHOULD YOUR ANIMAL HAVE A MEDICAL CONDITION, PROMPTLY SEE YOUR OWN VETERINARIAN. WE DO NOT OFFER PERSONALIZED MEDICAL DIAGNOSIS OR ANIMAL-SPECIFIC TREATMENT ADVICE. You should always obtain complete medical information about your veterinary product prescription (including their beneficial medical uses and possible adverse effects) by discussing the appropriate use of any veterinary product directly with the prescribing veterinarian.
Veterinary professionals may obtain complete medical information from the product's information leaflet. Information on these products may vary by country. Animal owners and veterinarians should check with local medical resources and regulatory authorities for information appropriate to their country. In addition, current regulations in many countries limit (or even prohibit in some instances) the ability of Novartis Animal Health Inc. to provide information and/or to respond directly to questions regarding its prescription products. Novartis Animal Health Inc., however, will respond to inquiries from and provide information to your qualified health care professional in accordance with local regulations.
Injectable Suspension
Product Type
PROGRAM IJS is an injectable suspension for flea control in cats
Description and Composition
Program Injectable is a suspension containing 0.1 g of lufenuron per ml. Following presentations are available:
PROGRAM 40 IJS, an injectable suspension in a prefilled single-dose syringe containing 0.4 ml, corresponding to 40 mg of lufenuron.
PROGRAM 80 IJS, an injectable suspension in a prefilled single-dose syringe containing 0.8 ml, corresponding to 80 mg of lufenuron
Properties
Lufenuron, the active ingredient of PROGRAM, is an insect development inhibitor (IDI) belonging to the group of benzoyl-phenyl-ureas (BPUs). Like all BPU's, lufenuron acts as a chitin synthesis inhibitor. Female fleas feeding on treated animals will produce eggs out of which no larvae will hatch. The interruption of the flea life cycle results in a long-term, very effective flea control on the animal as well as in the environment
Indications
PROGRAM INJ is an injectable suspension for cats for the prevention and control of flea infestations.
Dosage and Administration
PROGRAM injectable suspension is given parenterally at the minimum dose of 10mg lufenuron per kg body weight according to the following table:
|
Weight of cat |
Syringes |
|
Less than 4 kg |
1 syringe of PROGRAM 40 |
|
Greater than 4 kg |
1 syringe of PROGRAM 80 |
Each injection will provide a protection over a period of 6 months.
Treatment of existing infestations can begin at any time. In cases of severe infestations, the use of an adulticide during the first few weeks of the treatment may be necessary. Effective blood levels of lufenuron are achieved within 21 days.
PROGRAM is best used in a prophylactic way. In this case treatment should start in spring, before the beginning of the flea season, and repeated every six months.
All cats and dogs in a household must be treated in order to prevent the build up of developing fleas in the environment, thus establishing an infestation. For dogs use PROGRAM tablets
Special Precautions and Warnings
Do not use in dogs.
The injection should be carried out under aseptic conditions. The syringe must only be used once.
Formulations and Packages
PROGRAM injectable suspension for cats is available as prefilled sterile, disposable 1 ml syringes, containing a withdrawable volume of 0.4 and 0.8ml of suspension.
10 individually blistered syringes are packed in a cardboard box.
Two syringe sizes are available:
PROGRAM 40 containing 40 mg lufenuron.
PROGRAM 80 containing 80 mg lufenuron
U.S. Residents
This is an international website and is intended for residents outside the US.
If you are a Consumer or Veterinarian in the USA and have questions about our products, please call:
Novartis Technical Product Services Group
1-800-637-0281
Product Availability
Please note that not all products listed within this site may be available in all countries. Also, prescribing information and indications for products may differ from country to country, so please consult your local veterinarian for local prescribing and any other information you may be interested in.
Flea Infestation
Flea larvae and pupae usually live deep in the carpet pile. So although vaccuming helps, you will never get all of them. What's more, flea pupae are completly unaffected by household insecticides. That's why prevention really is better than cure.
Locations
Headquartered in Basel, Switzerland, and present in almost 40 countries, Novartis Animal Health employs approximately 2,700 associates worldwide.